Ocrelizumab (Anti-CD20)

製品コード：A2561         Batch: A256101

印刷

Ocrelizumab (Anti-CD20) is a recombinant humanized monoclonal IgG1 antibody that selectively targets CD20 antigen present on B-cells. It is used to treat relapsing remitting multiple sclerosis. MW:145.5 KD.

製品説明

CAS No. 637334-45-3
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Isotype Human IgG1
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 4.56mg/ml
Endotoxin Level ＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。